ctrl K

Price Alert

Xilio Therapeutics Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

0.70

-0.00 (-0.38%)

At close: Aug 15, 2025, 3:59 PM

0.70

-0.74%

After-hours: Aug 15, 2025, 06:54 PM EDT

Xilio Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	55.29M	44.7M	120.39M	198.05M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	1.56M	1.55M
Other Long-Term Assets	1.78M	1.6M	267K	1.95M
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	4.94M	3.42M	4.11M	4.46M
Total Current Assets	60.23M	48.13M	124.5M	202.52M
Property-Plant & Equipment	9.06M	11.2M	12.84M	13.6M
Goodwill & Intangibles	n/a	n/a	n/a	-5.09M
Total Long-Term Assets	10.84M	12.8M	14.67M	15.54M
Total Assets	71.08M	60.93M	139.16M	218.06M
Account Payables	2.57M	1.05M	3.13M	3.14M
Deferred Revenue	13.52M	n/a	n/a	8.75M
Short-Term Debt	n/a	3.31M	6.67M	n/a
Other Current Liabilities	4.21M	6.9M	82K	82K
Total Current Liabilities	27.26M	15.96M	21.12M	12.78M
Long-Term Debt	n/a	n/a	3.17M	9.63M
Other Long-Term Liabilities	n/a	n/a	45K	118K
Total Long-Term Liabilities	26.22M	8.14M	12.4M	19.85M
Total Liabilities	53.48M	24.1M	33.52M	32.63M
Total Debt	8.14M	11.46M	19.94M	20.54M
Common Stock	5K	3K	3K	3K
Retained Earnings	-383.75M	-325.51M	-249.11M	-160.89M
Comprehensive Income	n/a	n/a	n/a	-218.06M
Shareholders Equity	17.6M	36.83M	105.65M	185.43M
Total Investments	n/a	1.59M	1.56M	1.55M